All In MedTech

Device Trial Radar · NCT07666997

Safety of a Contraceptive Copper Vaginal Ring

Prospective Evaluation of the Safety of a Novel Copper Vaginal Contraceptive Ring (CVR)

Last checked: Nov 19, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

8

Planned (sponsor's estimate)

Start

Nov 15, 2026

Primary completion

Apr 30, 2027

Study completion Jun 30, 2027

Sponsor

Lead sponsor
Elle, MD Biotechnologies Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Ottawa Hospital Research Institute; National Research Council Canada
First posted
Jun 24, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
No
Who can join
Female only, from 18 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Many birth control options today come with unwanted side effects or risks. Hormonal methods can affect both mental and physical health, while devices like copper IUDs carry risks such as uterine perforation or infection. This study is testing a new option: a copper vaginal ring (CVR) - a non-hormonal, non-invasive contraceptive that can be self-inserted, similar to a other vaginal rings like NuvaRing or Annovera. The main goal of this study is to assess whether the copper vaginal ring is safe to use. Researchers will also look at how comfortable and easy it is to use, whether participants follow the instructions, and how much copper accumulates in cervical mucus and vaginal fluid during use. The study will enroll up to 8 women of childbearing age. Participants wear the ring continuously for 28 days, inserting it on Day 5 of their menstrual cycle. Over the course of the study, participants will attend 8 in-person clinic visits, which include pelvic exams, vaginal swabs, blood draws, and cervical mucus collection. On the day the ring is removed (Day 28), small tissue samples (biopsies) are taken from the vagina and uterine lining. At the end of the study, participants will complete a short survey about their experience with the ring.

Conditions

  • Contraception
  • Birth Control
  • Pregnancy Prevention

Interventions

  • Vaginal RingDevice

    The copper vaginal ring (CVR) is a non-hormonal vaginal ring designed for prevention of pregnancy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse Events [Safety]Time frame: From enrollment to the end of study participation on Day 35

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.